Cancer Epidemiology, screening, Diagnosis & Prognosis

The Epidemiology of Cancer is the study of the factors affecting Cancer, a way to conclude possible tendencies and causes. The study of Cancer Epidemiology practices Epidemiological Methods to discover the cause of Cancer and to recognize and develop enhanced treatments. This extent of study must cope with difficulties of lead time bias and length time bias. Lead time bias is the theory that primary diagnosis may artificially inflate the survival statistics of a Cancer, without actually improving the natural history of the disease. Length bias is the concept that tender growing, more lethargic Tumors are more likely to be recognised by Screening Tests, but improvements in diagnosing more cases of indolent Cancer may not translate into better patient outcomes after the implementation of Screening Programs.

Most Cancers are originally known either because of the appearance of signs or symptoms or through Screening. Neither of these leads to a Definitive Diagnosis, which comprises the examination of a tissue sample by a pathologist. People with suspected Cancer are observed with medical tests. These generally include Blood Tests, CT Scans, X-rays and Endoscopy.

Screenings can find initial Cancer, when it’s most curable. Cancer Screening aims to identify Cancer before symptoms appear. This may include blood tests, urine tests, other tests, or Medical Imaging. The aids of screening in terms of Cancer Prevention, early detection and subsequent treatment must be weighed beside any harm. Worldwide screening, Population Screening or Mass Screening involves screening everyone, generally within a definite age group. Selective Screening detects people who are known to be at advanced risk of developing Cancer, such as people with a family history of Cancer.

  • Circulating tumor cells (CTCs) towards cancer Diagnosis
  • Microfluidic device for cancer screening
  • Cancer Staging
  • Early detection and diagnosis of Cancer
  • Early detection and diagnosis of Cancer

Related Conference of Cancer Epidemiology, screening, Diagnosis & Prognosis

June 23-24, 2021

41st Euro Congress on Cancer Science & Therapy

Barcelona, Spain
June 27-27, 2021

1st Webinar on Oncology and Radiology

London, UK
June 28-29, 2021

21st Global Summit on Breast Cancer

Amsterdam, Netherlands
July 12-13, 2021

8th World Congress on Epigenetics and Chromosome

Zurich, Switzerland
July 12-13, 2021

World Congress on Women Oncology & Care

Melbourne, Austria
July 12-13, 2021

Global Immuno-Oncology & Biomarkers Summit

Melbourne, Australia
July 12-13, 2021

World Congress on Gastrointestinal Cancer

Vienna, Australia
July 26-27, 2021

International Conference on Oncology and Radiology

Singapore, Singapore
July 27-27, 2021

1st Webinar on Skin Cancerr

London, UK
July 28-29, 2021

3rd Asia Pacific Oncology and Cancer Conference

Tokyo, Japan
August 05-06, 2021

11th World Congress on Breast Cancer & Therapies

Amsterdam, Netherlands
August 18-19, 2021

2nd World Cancer, Oncology and Therapeutics Congress

Munich, Germany
August 23-24, 2021

42nd Annual Summit on Oncology and Cancer

Tokyo, Japan
August 25-26, 2021

40th World Cancer Conference

Vienna, Austria
September 08-09, 2021

6th Global summit on Cancer Science and Oncology

Paris, France
September 20-21, 2021

5th Global Summit on Cancer

Tokyo, Japan
September 24-25, 2021

Annual Conference on Cancer Research

Miami, USA
September 29-30, 2021

3rd International conference on Women Oncology and women's health

Zurich, Switzerland
October 04-05, 2021

11th World Congress on Breast Cancer

Barcelona, Spain
October 07-08, 2021

19th Asia Pacific Oncologists Annual Meeting

London, Aland Islands
October 21-22, 2021

5th Global Summit on Cancer and Oncology Research

Zurich, Switzerland
November 22-23, 2021

9th Annual Congress on Pulmonary and Critical Care

, Singapore

Cancer Epidemiology, screening, Diagnosis & Prognosis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in